首頁 › 脂肪性肝病 › 加州 › Los Angeles
Los Angeles, CA 的 脂肪性肝病 臨床試驗
8 項針對 脂肪性肝病 的研究正在 Los Angeles（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, Los Angeles
- 89bio Clinical Study Site, Los Angeles
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
招募中2 期
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
招募中3 期
- Los Angeles Institute for Metabolic Research, Los Angeles
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
招募中3 期
- Akero Clinical Study Site, Los Angeles
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, Los Angeles
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
招募中2 期
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, Los Angeles
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
招募中1/2 期歡迎健康志工
- Velocity Clinical research, Los Angeles
其他城市的 脂肪性肝病 試驗
- San Antonio, TX17 項研究
- Miami, FL16 項研究
- New York City, NY16 項研究
- San Diego, CA14 項研究
- Austin, TX13 項研究
- Houston, TX13 項研究
- Richmond, VA12 項研究
- Tucson, AZ10 項研究
- Chandler, AZ10 項研究
- Orlando, FL9 項研究
- St. Louis, MO9 項研究
- Dallas, TX9 項研究
Los Angeles 的其他研究
- 非小細胞肺癌87 項研究
- 癌症（所有類型）74 項研究
- 乳癌73 項研究
- 前列腺癌61 項研究
- 大腸直腸癌59 項研究
- 轉移性癌症57 項研究
- 卵巢癌50 項研究
- 肺癌45 項研究
- 頭頸部鱗狀細胞癌42 項研究
- 胰臟癌35 項研究
- 子宮內膜癌34 項研究
- 黑色素瘤34 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。